Find Reports
Select Report Type
Reimbursement Review
Displaying 1226 - 1250 of 1422
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| vorinostat | Zolinza | vorinostat | Cutaneous T-cell lymphoma | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0015-000 | |||
| baloxavir marboxil | Xofluza | baloxavir marboxil | Influenza | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0016-000 | |||
| talazoparib | Talzenna | talazoparib | Breast Cancer | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0017-000 | |||
| mepolizumab | Nucala | mepolizumab | Eosinophilic granulomatosis with polyangiitis | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0018-000 | |||
| Onivyde for Metastatic Pancrea... | Onivyde | Nanoliposomal Irinotecan | Cancelled | PC0096-000 | |||||
| Cyramza for Non-Small Cell Lun... | Cyramza | Ramucirumab | Cancelled | PC0078-000 | |||||
| Idarucizumab (Drug Plan Submis... | Praxbind | Idarucizumab (Drug Plan Submission) | Reversal of dabigatran anticoagulant effects | Withdrawn | SR0492-000 | ||||
| Venclexta for Chronic Lymphocy... | Venclexta | Venetoclax | Withdrawn | PC0087-000 | |||||
| Liraglutide | Victoza | Liraglutide | Diabetes Mellitus, Type 2 | Withdrawn | SR0505-000 | ||||
| Avastin for Malignant Pleural ... | Avastin | Bevacizumab | Withdrawn | PC0100-000 | |||||
| trabectedin | N/A | trabectedin | Soft tissue and uterine leiomyosarcoma | Active | PX0377-000 | ||||
| Esophageal or Gastroesophageal... | Esophageal or Gastroesophageal Junction Cancer | Active | PH0061-000 | ||||||
| Multiple Myeloma | Multiple Myeloma | Merged | PH0060-000 | ||||||
| Pharmaceutical Reviews Update ... | |||||||||
| Large B cell lymphoma | Large B cell lymphoma/ Lymphome B à grandes cellules | Complete | PH0064-000 | ||||||
| Colorectal cancer | Colorectal cancer | Complete | PH0062-000 | ||||||
| Diffuse large B cell lymphoma ... | Diffuse large B | Open for Input | PH0078-000 | ||||||
| Hodgkin lymphoma | Hodgkin lymphoma | Open for Input | PH0079-000 | ||||||
| Prostate cancer | Prostate cancer | Open for Input | PH0073-000 | ||||||
| Multiple myeloma | Multiple myeloma | Open for Input | PH0074-000 | ||||||
| Renal cell carcinoma | Renal cell carcinoma | Open for Input | PH0075-000 | ||||||
| Mifepristone and misoprostol | Mifegymiso | Mifepristone and misoprostol | Medical termination of pregnancy (gestational age up to 49 days) | Withdrawn | SR0473 -000 | ||||
| Adcetris for Hodgkin Lymphoma... | Adcetris | Brentuximab vedotin | Withdrawn | PC0086-000 | |||||
| Saxagliptin | Onglyza | Saxagliptin | Diabetes mellitus, type 2 | Withdrawn | SR0280-000 | ||||
| Rivaroxaban | Xarelto | Rivaroxaban | Deep-vein thrombosis without symptomatic pulmonary embolism | Complete | SF0295-000 |
Health Technology Review
Displaying 576 - 600 of 600
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 1226 - 1250 of 2132
Please scroll or swipe to the right to view the full content.